Safety and Efficacy of Therapeutic Agents in Viral Pneumonia in Immunosuppressed Patients.
INTRODUCTION/OBJECTIVE Immunosuppressed Patients (ISP) - defined by congenital or acquired deficiencies in systemic defense mechanisms - are disproportionately susceptible to viral respiratory infections. Agents such as SARS-CoV-2, Respiratory Syncytial Virus (RSV), influenza A and B, and Cytomegalovirus (CMV) cause si...